Genomics & Disease Prevention |
|
|
Pictures
RDT 1000 Unveiling
Left to right Chris McNary President and Chief Executive Officer RainDance Technologies Sir Richard Roberts F R S Nobel Laureate member of RainDance Technologies Scientific Advisory Board and Founder amp Chief Scientific Officer of New England Biolabs Daniel O Connell Secretary of Housing and Economic Development Commonwealth of Massachusetts Robert Coughlin President amp Chief Executive Officer Massachusetts Biotechnology Council and Steve Becker Vice President Commercial Operations RainDance Technologies The group unveiled a rendering of RainDance Technologies new RDT 1000 instrument at the dedication of the company s new headquarters and operations building in Lexington Mass on Sept 26 2008 RainDance is a provider of droplet based microfluidic technology for use in biomedical applications and genomics research in the prediction and prevention of human disease
Coughlin Roberts
Robert Coughlin President amp Chief Executive Officer Massachusetts Biotechnology Council speaks with Sir Richard Roberts F R S Nobel Laureate member of RainDance Technologies Scientific Advisory Board and Founder amp Chief Scientific Officer of New England Biolabs at the dedication of RainDance Technologies new headquarters and operations building in Lexington Mass on Sept 26 2008 RainDance is a provider of droplet based microfluidic technology for use in biomedical and genomics research applications in the prediction and prevention of human disease
Roberts McNary O Connell
Left to right Sir Richard Roberts F R S Nobel Laureate member of RainDance Technologies Scientific Advisory Board and Founder amp Chief Scientific Officer of New England Biolabs with Chris McNary President and Chief Executive Officer RainDance Technologies and Daniel O Connell Secretary of Housing and Economic Development Commonwealth of Massachusetts at the dedication of RainDance Technologies new headquarters and operations building in Lexington Mass on Sept 26 2008 RainDance is a provider of droplet based microfluidic technology for use in biomedical and genomics research applications in the prediction and prevention of human disease

Not Signed In -

